Lactobacillus reuteri Strain Combination In Helicobacter pylori Infection

罗伊乳杆菌 医学 胃肠病学 安慰剂 内科学 尿素呼气试验 幽门螺杆菌 益生菌 抗生素 微生物学 幽门螺杆菌感染 细菌 生物 病理 遗传学 替代医学
作者
Ruggiero Francavilla,Lorenzo Polimeno,Antonella Demichina,Giovanni Maurogiovanni,Mariabeatrice Principi,Giuseppe Scaccianoce,Enzo Ierardi,Francesco Russo,Giuseppe Riezzo,Alfredo Di Leo,Luciano Cavallo,A. Francavilla,James Versalovic
出处
期刊:Journal of Clinical Gastroenterology [Lippincott Williams & Wilkins]
卷期号:48 (5): 407-413 被引量:103
标识
DOI:10.1097/mcg.0000000000000007
摘要

The goals of this study were to investigate the role of a new probiotic preparation (Lactobacillus reuteri DSM 17938 and L. reuteri ATCC PTA 6475) in Helicobacter pylori infection.Specific probiotic strains play a role in H. pylori infection for their ability to decrease bacterial load and gastritis, prevent antibiotic-associated side effects, and increase the eradication rate.This is a prospective, double-blind, randomized, placebo-controlled study in a tertiary care setting. A total of 100 H. pylori-positive naive patients received either L. reuteri combination (2×10 Colony Forming Units) or placebo during a 3-phase study (pre-eradication, eradication, and follow-up). All underwent C urea breath test (C-UBT), blood assessments of gastrin-17 (G17), endoscopy, and the Gastrointestinal Symptom Rating Scale. Eradication was confirmed by C-UBT 8 weeks after the completion of therapy.Fifty patients were allocated in each group. During pre-eradication period, C-UBT δ decreased by 13% in L. reuteri combination as compared with a 4% increase in placebo (-13.2±34% vs. 4.3±27%; P<0.03). During eradication, GSRS increased significantly in placebo as compared with L. reuteri combination (6.8±2.9 vs. 4±3.1; P<0.01). Significantly less patients in L. reuteri combination as compared with placebo-reported side effects (40.9% vs. 62.8%; P<0.04). An abnormal G17 value was found in patients receiving placebo as compared with L. reuteri combination (28% vs. 12%; P<0.02). Eradication rate was 75% in L. reuteri combination and 65.9% in placebo (P=NS). L. reuteri combination increased eradication rate by 9.1% (odds ratio: 1.5).L. reuteri combination alone is able to exert an inhibitory effect on H. pylori growth, and when administered with eradication therapy, it determines a significant reduction in antibiotic-associated side effects. Moreover, L. reuteri combination was able to decrease serum G17 levels and to (not significantly) increase the H. pylori-eradication rate.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI5应助大方研究生采纳,获得10
刚刚
芷莯发布了新的文献求助10
刚刚
刚刚
雍以菱完成签到,获得积分10
1秒前
2秒前
动听靖发布了新的文献求助10
2秒前
2024dsb完成签到 ,获得积分10
2秒前
2秒前
乐乐应助科研小民工采纳,获得100
3秒前
3秒前
藜誌完成签到,获得积分10
3秒前
3秒前
3秒前
4秒前
17858925711关注了科研通微信公众号
4秒前
酷波er应助yoyo采纳,获得10
4秒前
高高访文完成签到,获得积分10
5秒前
科研通AI5应助欣欣杨采纳,获得10
5秒前
Sun发布了新的文献求助10
6秒前
希望天下0贩的0应助jeronimo采纳,获得10
6秒前
xy发布了新的文献求助10
6秒前
SciGPT应助weizhao采纳,获得10
6秒前
一只橙子完成签到,获得积分10
6秒前
8秒前
友好的海之完成签到,获得积分10
8秒前
wanci应助幸福广山采纳,获得10
9秒前
zhoup完成签到,获得积分10
10秒前
刘源文发布了新的文献求助10
11秒前
12秒前
闾丘惜寒完成签到,获得积分10
12秒前
12秒前
12秒前
Cocoa发布了新的文献求助10
13秒前
13秒前
14秒前
15秒前
大胆的问夏完成签到,获得积分10
15秒前
宋德宇完成签到,获得积分10
15秒前
ll应助故意的初阳采纳,获得10
15秒前
OnionJJ完成签到,获得积分10
15秒前
高分求助中
Les Mantodea de Guyane Insecta, Polyneoptera 2500
Technologies supporting mass customization of apparel: A pilot project 450
China—Art—Modernity: A Critical Introduction to Chinese Visual Expression from the Beginning of the Twentieth Century to the Present Day 430
A Field Guide to the Amphibians and Reptiles of Madagascar - Frank Glaw and Miguel Vences - 3rd Edition 400
China Gadabouts: New Frontiers of Humanitarian Nursing, 1941–51 400
The Healthy Socialist Life in Maoist China, 1949–1980 400
Walking a Tightrope: Memories of Wu Jieping, Personal Physician to China's Leaders 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3790056
求助须知:如何正确求助?哪些是违规求助? 3334710
关于积分的说明 10271870
捐赠科研通 3051185
什么是DOI,文献DOI怎么找? 1674513
邀请新用户注册赠送积分活动 802634
科研通“疑难数据库(出版商)”最低求助积分说明 760828